Patel S,Chiu RG,Rosinski CL,Ansari D,Chaker AN,Nunna RS .2020 .Outcomes of Spinal Giant Cell Tumour of Bone in Adult Patients: A National Cancer Database Analysis. World Neurosurg, 144 : e296-305.
Turcotte RE,Wunder JS,Isler MH,Bell RS,Schachar N,Masri BA .2002 .Giant cell tumour of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res, 397 : 248-58.
Choi JH,Ro JY .2021 .The 2020 WHO Classification of Tumours of Soft Tissue: Selected Changes and New Entities. Adv Anat Pathol, 28(1) : 44-58.
Thomas DM,Skubitz KM .2009 .Giant cell tumour of bone. Curr Opin Oncol, 21(4) : 338-44.
Forsyth RG,Krenács T,Athanasou N,Hogendoorn PCW,Cancers PCW .2021 .Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis. , 13(20) : 5119.
Peters S,Clézardin P,Márquez-Rodas I,Niepel D,Gedye C. .2019 .The RANK-RANKL axis: An opportunity for drug repurposing in cancer?. Clin Transl Oncol, 21(8) : 977-91.
Balke M,Hardes J .2010 .Denosumab: a breakthrough in treatment of giant-cell tumour of bone?. Lancet Oncol, 11(3) : 218-9.
Thomas D,Henshaw R,Skubitz K,Chawla S,Staddon A,Blay JY .2010 .Denosumab in patients with giant-cell tumour of bone: an openlabel, phase 2 study. Lancet Oncol, 11(3) : 275-80.
Atrayee BM,Chawla SP .2021 .. Giant Cell Tumour of Bone: An Update. Curr Oncol Rep, 23(5) : 51.
Girolami I,Mancini I,Simoni A,Baldi GG,Simi L,Campanacci D .2016 .Denosumab treated giant cell tumour of bone: A morphological, immunohistochemical and molecular analysis of a series. J Clin Pathol, 69(3) : 240-7.
Martin-Broto J,Cleeland CS,Glare PA,Engellau J,Skubitz KM,Blum RH .2014 .Effects of denosumab on pain and analgesic use in giant cell tumour of bone: interim results from a phase II study. Acta Oncol, 53(9) : 1173-9.
Rutkowski P,Ferrari S,Grimer RJ,Stalley PD,Dijkstra SPD,Pienkowski A .2015 .Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumour of bone. Ann Surg Oncol, 22(9) : 2860-8.
Serlin RC,Mendoza TR,Nakamura Y,Edwards KR .1995 .When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain, 61(2) : 277-84.
Guyatt GH,Osoba D,Wu AW,Wyrwich KW,Norman GR .2002 .Methods to explain the clinical signifi cance of health status measures. Mayo Clin Proc, 77(4) : 371-83.
Enneking WF,Dunham W,Gebhardt MC,Malawar M,Pritchard DJ M .1993 .A system for the functional evaluation of reconstructive procedures after surgical treatment of tumours of the musculoskeletal system. Clin Orthop Relat Res, : 241-6.
Traub F,Singh J,Dickson BC,Leung S,Mohankumar R,Blackstein ME .2016 .Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Eur J Cancer, 59 : 1-12.
Campanacci M,Baldini N,Boriani S,Sudanese A .1987 .Giant-cell tumour of bone. J Bone Joint Surg Am, 69(1) : 106-14.
Amin MS,Chaudhary AA,Shah F .2017 .Management of Campanacci type III giant cell tumour. Int J Orthop Sci, 3(1) : 836-41.
Puri A,Gulia A,Hegde P,Verma V,Rekhi B .2019 .Neoadjuvant denosumab: Its role and results in operable cases of giant cell tumour of bone. Bone Joint J, : 170-7.
Yue J,Sun W,Li S. .2022 .Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumour of bone: A randomized clinical trial. J Bone Oncol, 35 : 100441.
Palmerini E,Pazzaglia L,Cevolani L,Pratelli L,Pierini M,Quattrini I .2022 .Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumours of Bone (GCTB): A Phase II Trial Correlative Study. Cancers, 14(12) : 2863.
Branstetter DG,Nelson SD,Manivel JC,Blay JY,Chawla S,Thomas D .2012 .Denosumab Induces Tumour Reduction and Bone Formation in Patients with Giant-Cell Tumour of Bone. Clin Cancer Res, 18 : 4415-24.
Lim CY,Liu X,He F,Liang H,Yang Y,Ji T .2020 .Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy. Bone Joint J, : 177-85.
Niu X,Yang Y,Wong KC,Huang Z,Ding Y .2019 .Giant cell tumour of the bone treated with denosumab: How has the blood supply and oncological prognosis of the tumour changed. J Orthop Transl, 18 : 100-8.
Deventer N,Budny T,Gosheger G,Rachbauer A,Puetzler J,Theil JC .2022 .Giant cell tumour of bone: A single center study of 115 cases. J Bone Oncol, 33 : 100417.
Errani C,Tsukamoto S,Leone G,Righi A,Akahane M,Tanaka Y .2018 .Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumour of Bone Treated with Curettage. J Bone Joint Surg Am, 100(6) : 496-504.
Chinder PS,Hindiskere S,Doddarangappa S,Pal U .2019 .Evaluation of Local Recurrence in Giant-Cell Tumour of Bone Treated by Neoadjuvant Denosumab. Clin Orthop Surg, 11(3) : 352-60.